Navigation Links
PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29
Date:10/24/2011

MONTGOMERYVILLE, Pa., Oct. 24, 2011 /PRNewswire/ -- PhotoMedex, Inc. (NASDAQ: PHMD), an innovator of medical devices, including the XTRAC® excimer laser (www.XTRACLaser.com), is offering a special co-pay reimbursement program to increase access to XTRAC psoriasis treatments for children, an underserved population of psoriasis patients.

The offer is being presented in recognition of World Psoriasis Day on October 29. Conceived by patients for patients, World Psoriasis Day is a global event focusing on increasing awareness about the burdens of living with psoriasis, a severe chronic inflammatory disease that affects all ages, genders, races and ethnicities.  Globally, more than 125 million people suffer from psoriasis/psoriatic arthritis, many of whom are children. In the United States alone, more than 20,000 children a year are diagnosed.

The painless XTRAC excimer laser provides targeted phototherapy treatment for psoriasis; offering a safe, effective treatment with longer lasting results. Other treatment options for psoriasis, such as topical steroids, full-body UVB, systemic medications and biologics can have dangerous side effects.  The XTRAC is the safest choice for children, as it accurately targets only the affected areas with safe, phototherapy light. Because there is currently no cure for psoriasis, patients who develop the disease at a young age need to utilize a safe, effective treatment that will not produce negative, long-term side effects.  The XTRAC excimer laser is the only clinically proven, FDA-cleared dermatology excimer laser with independent safety and quality certifications.

"For children, the treatment options are often more limited than for adults, and those that are available often have many dangers associated with them or become ineffective over time," said Dr. Barry Auster, dermatologist at Oakland Aesthetic Dermatology in Farmington Hills, Mich. "The XTRAC excimer laser treatment is a great option for children because it provides safe, effective and lasting results that eliminate the need for messy creams or steroids. This co-pay reimbursement offer can help children, who may have otherwise not considered the treatment because of costs, finally experience relief."

Inconsistent care and access to care are two major issues for all psoriasis sufferers but are even more of a concern for children.  According to a recent study, children with psoriasis are most likely to receive inconsistent care, and the course of treatment prescribed may depend on whether they see a pediatrician, dermatologist or internist. In 3.8 million visits, about 63 percent of kids saw a dermatologist, 17 percent saw a pediatrician, and 14 percent went to an internist. Researchers found that pediatricians, dermatologists and internists often take different approaches to how they treat children with psoriasis, including the types and strengths of medication they use. It is important that psoriasis sufferers see a qualified dermatologist who offers the latest, safest and most effective treatment options, such as the XTRAC laser.

Broad coverage of the XTRAC treatments for psoriasis by Medicare and all major insurance companies now provides greater access to care for psoriasis sufferers who have spent their lives suffering from dry, red and itchy skin, among other symptoms associated with the disease.

For more information about the XTRAC excimer laser, visit www.XTRACLaser.com. The website features a telecare center where patients can speak directly with highly experienced clinical specialists about the XTRAC laser therapy. The specialists also will assist those interested in making appointments with physicians experienced in providing XTRAC laser treatments.

Connect with XTRAC on Twitter - www.Twitter.com/XTRACPsoriasis and on

Facebook - http://www.facebook.com/pages/Xtrac-Psoriasis-Vitiligo/159178087466723

About PhotoMedex

PhotoMedex is a leader in the development, manufacturing, and global marketing of dermatology products and techniques focused on advancing cost-effective technologies that provide patients with better outcomes and a higher quality of life. The company is uniquely positioned to research and commercialize therapies that innovatively combine both medical devices and science-based aesthetic products. Medical devices include the XTRAC®  Excimer Laser for the treatment of skin diseases like psoriasis and vitiligo; and the Omnilux™ non-laser light-emitting diodes (LED) for the treatment of clinical and aesthetic dermatological conditions, including acne, photodamage, skin rejuvenation, and wound healing. Adding to these therapies, the company markets a broad range of specialty skin-care products based upon its clinically proven DNA + Copper Peptide technologies for skin heath and Copper Peptide Complexes for hair and wound care, including its NEOVA®, DNA Damage Control™, Tricomin® and Graftcyte® brands. PhotoMedex sells directly to dermatologists; plastic and cosmetic surgeons, spas; salons; and, through strategic partners, in the consumer market. In addition, the company manufactures and distributes surgical lasers and disposables to hospitals and surgery centers for procedures in multiple surgical specialties.  For more information please visit www.photomedex.com.

 


'/>"/>
SOURCE PhotoMedex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis
2. PhotoMedexs Itching to Win Contest Offers Free Phototherapy Treatments With the XTRAC Laser to Deserving Psoriasis Patients Nationwide
3. PhotoMedex Launches New Patient-Focused XTRAC Laser Website
4. Practices Using SuccessEHS See Immediate Increases in Productivity After Go-Live
5. Research Suggests FORTEO® Significantly Increases Bone Strength
6. Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
7. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
8. Fero Industries Increases Sucanon® Promotion in Mexico with Physician Distributed Sample Packages
9. HeartSine® Increases AED System Warranty to Longest in the Industry
10. Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent
11. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):